Who We Are
Nice to Meet You
Kestra Medical Technologies is a wearable medical device and digital healthcare company that helps protect patients with diagnostic and therapeutic technologies that are intuitive, intelligent, and mobile.
Kestra innovations empower providers and patients to collaborate towards better care and improved outcomes.
Our Mission
Kestra’s Mission is to provide innovative, intuitive medical technologies to protect and support at-risk patients.
Our Team of professionals with deep expertise in Class III therapeutic medical devices works together focused on our Core principles of innovation, collaboration, and execution.
Kestra's initial product, the ASSURE® system, includes the ASSURE WCD, ASSURE patient app, and Kestra CareStation™ remote patient data platform, designed to work in concert to offer confidence, comfort, and connection to patients—and clarity for healthcare providers.
ASSURE Cardiac Recovery System
Empathy Powered Design
Kestra deploys a design approach we call Empathy Powered Design™ that focuses intensively on the patient experience—and the experience of those who care for them, both healthcare providers and patients’ loved ones and families.
As Kestra grows, we aim to create best-in-class products and platforms through active research and product development, always putting safety, efficacy, ease of use, and patient and caregiver empowerment at the forefront.
Leadership
Kestra was founded in 2014 by leaders from the automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD) industries, who were inspired to develop modern, wearable, advanced technology diagnostic and therapy products.
Brian Webster
President and Chief Executive Officer
Traci Umberger
General Counsel and Chief Administrative Officer
Vaseem Mahboob
Chief Financial Officer
Phillip Foshee
Vice President, Research & Development
Debra Schotz
Senior Vice President, Marketing
Michael Gill
Senior Vice President, Commercial Operations
Beverly Magrane
Vice President, Quality and Regulatory Affairs
Jeff Laub
Vice President, Operations and Supply Chain
Gordon Teddy
Vice President, IT & Customer Experience
Keith Claeys
Vice President, Finance
Laura Gustavson
Vice President, Clinical Marketing
Simpson Kwan
VP Financial Planning & Analysis
Christine Schlenker
Vice President, Revenue Cycle Management
Board of Directors
Christopher Gordon
Orly Mishan
Jeffrey Schwartz
Mary Kay Ladone
Toby AuWerter
Brian Webster
Traci Umberger
Kestra Culture
Join Our Team
At Kestra we offer opportunities to work on unique projects, across multiple disciplines, in a collaborative, creative, and fast-paced environment. We foster innovation, reward performance, and have fun.
Compliance and Ethics
Kestra maintains a continuing commitment to conducting our business honestly, ethically, and in accordance with applicable laws, with respect to our team members, customers, marketplace, and global community.
We are guided by our Code of Conduct and Business Code of Conduct, which are continually reviewed and enhanced as appropriate or as required by applicable laws and regulations.
Press Releases
Kestra Medical Technologies Surpasses 200 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System
Additional Health Plans Contract with Kestra Medical Technology Services, Inc., increasing patient access to the ASSURE system as a covered service.
Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference
New ASSURE WCD Enhanced Arrythmia Capabilities Featured
ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award
ASSURE System Honored as One of the Year’s Best Designed Cardiovascular Devices
ASSURE Wearable Cardioverter Defibrillator (WCD) System Demonstrates Low False Alarm Rates, High Patient Compliance in Clinical Study
Kestra Medical Technologies announced today that the company’s ASSURE® Wearable Cardioverter Defibrillator (WCD) system is effective at reducing false shock alarms and improving patient comfort, according to results of the ASSURE WCD Clinical Evaluation - Detection and Safety Study
Kestra Medical Technologies Receives FDA Premarket Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)
Kestra™ Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE® (WCD) system.
Investor Relations
Kestra is a closely held private company and a portfolio company of Bain Capital, one of the world’s leading alternative investment firms with deep global experience in healthcare.
Investor Inquiries
Contact Investor Relations
investor.relations@kestramedical.com
